Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Tuberculosis (Edinburgh, Scotland)|December 8, 2024
Utility of pleural fluid-derived extracellular vesicles as a source of Mycobacterium tuberculosis antigens MPT51 and MPT64 for pleural TB diagnosis: a proof-of-concept studyNeha Jindal, Pratibha Sharma, Sachin Punia, et al.
Mycopathologia|June 8, 2023
Characterization of Treatment Response Outcomes in Chronic Pulmonary Aspergillosis: CPAnet Definitions Versus the Existing CriteriaInderpaul Singh Sehgal, Kajal Arora, Oliver A Cornely, et al.
Lung India : Official Organ of Indian Chest Society|April 30, 2022
A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalitiesSahajal Dhooria, Venkata Nagarjuna Maturu, Deepak Talwar, et al.
Mycoses|May 16, 2023
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus-A case-control studyDeepak Garg, Kathirvel Soundappan, Ritesh Agarwal, et al.
Nanotheranostics|January 2, 2025
Development and assessment of a novel magnetic nanoparticle antibody-conjugate and aptamer-based assay (MNp-Ab-Ap assay) for the rapid diagnosis of pleural tuberculosisPratibha Sharma, Rakesh Kumar Gupta, Simran Aittan, et al.
Mycoses|May 20, 2024
Innate and adaptive immune responses in subjects with CPA secondary to post-pulmonary tuberculosis lung abnormalitiesNaresh Kumar Chirumamilla, Kanika Arora, Mandeep Kaur, et al.
Ocular Immunology and Inflammation|February 9, 2018
Role of CT Chest and Cytology in Differentiating Tuberculosis from Presumed Sarcoidosis in UveitisReema Bansal, Amod Gupta, Ritesh Agarwal, et al.
The Indian Journal of Medical Research|June 16, 2023
Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumoniaSahajal Dhooria, Siddhant Arora, Shivani Chaudhary, et al.
Lung India : Official Organ of Indian Chest Society|September 20, 2013
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendationsDheeraj Gupta, Ritesh Agarwal, Ashutosh Nath Aggarwal, et al.
Plos One|March 30, 2023
Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trialSanjeev Sinha, Himanshu Thukral, Imtiyaz Shareef, et al.
Pageof 14